Downriver Surgery Center, Pc Dentist - Oral and Maxillofacial Surgery Medicare: Medicare Enrolled Practice Location: 1823 Fort St, Wyandotte, MI 48192 Phone: 734-285-2550 Fax: 734-285-5375 |
Veizaj Dentistry Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2244 Ford Ave, Wyandotte, MI 48192 Phone: 734-282-2019 |
Periodontic Pllc Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 3589 Fort St, Wyandotte, MI 48192 Phone: 734-281-1414 |
Drs Hunter & Lupini Pc Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 1605 Fort Street, Wyandotte, MI 48192 Phone: 734-282-4100 Fax: 734-282-5420 |
Timothy D. Andres D.d.s. Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1717 Ford Ave, Wyandotte, MI 48192 Phone: 734-285-3100 Fax: 734-285-4277 |
Jeremy M Bezzo Dds Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 45 Elm St, Wyandotte, MI 48192 Phone: 734-281-2710 Fax: 734-281-8836 |
Benson Dental Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1404 Ford Avnue, Wyandotte, MI 48192 Phone: 734-285-2575 Fax: 734-285-2758 |
Wyandotte Family Dental, Pllc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 2244 Ford Ave, Wyandotte, MI 48192 Phone: 734-282-2019 Fax: 734-282-1976 |
Bliss Oral & Facial Surgery Dentist - Oral and Maxillofacial Surgery Medicare: Not Enrolled in Medicare Practice Location: 2201 Ford Ave, Wyandotte, MI 48192 Phone: 734-282-4224 Fax: 724-282-7361 |
Amazing Dental Wyandotte Pllc Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 1805 Fort St, Wyandotte, MI 48192 Phone: 248-910-4819 |
News Archive
Daily consumption of dark chocolate can reduce cardiovascular events, such as heart attacks and strokes, in people with metabolic syndrome (a cluster of factors that increases the risk of developing heart disease and diabetes), finds a study published on bmj.com today.
Genta Incorporated today announced top-line results from AGENDA, the Company's Phase 3 trial of Genasense® (oblimersen sodium) Injection in patients with advanced melanoma. AGENDA is a randomized, double-blind, placebo-controlled trial of dacarbazine administered with or without Genasense® in patients who have not previously received chemotherapy.
A new study aims to better understand the role of schools in SARS-CoV-2 transmission by evaluating infections at two independent schools.
Scientists have discovered two key proteins that guide one of the two groups of pathogenic bacteria to make their hardy outer shells - their defense against the world.
› Verified 7 days ago